[
  {
    "ts": null,
    "headline": "DexCom’s Q1 Earnings Call: Our Top 5 Analyst Questions",
    "summary": "DexCom’s first quarter was met with a positive response from the market, as the company delivered revenue ahead of Wall Street expectations and maintained strong growth momentum. Management attributed this performance to robust demand, record new patient additions, and successful navigation of short-term supply challenges. CEO Kevin Sayer highlighted that the company’s expanded commercial reach, recent product launches, and broader patient access were key to driving acceleration in new customer",
    "url": "https://finnhub.io/api/news?id=dc91d67e40a8606046cb348613f65fd6064803cf773b6e2012db9ea04422a1d1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750925663,
      "headline": "DexCom’s Q1 Earnings Call: Our Top 5 Analyst Questions",
      "id": 135558898,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "DexCom’s first quarter was met with a positive response from the market, as the company delivered revenue ahead of Wall Street expectations and maintained strong growth momentum. Management attributed this performance to robust demand, record new patient additions, and successful navigation of short-term supply challenges. CEO Kevin Sayer highlighted that the company’s expanded commercial reach, recent product launches, and broader patient access were key to driving acceleration in new customer",
      "url": "https://finnhub.io/api/news?id=dc91d67e40a8606046cb348613f65fd6064803cf773b6e2012db9ea04422a1d1"
    }
  }
]